Kevin Geoffrey Birkett's most recent trade in Ensysce Biosciences Inc was a trade of 50,000 Stock Option done . Disclosure was reported to the exchange on Feb. 17, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ensysce Biosciences Inc | Kevin Geoffrey Birkett | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option | |
| Ensysce Biosciences Inc | Kevin Geoffrey Birkett | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 329,250 | 329,250 | - | - | Stock Option | |
| Ensysce Biosciences Inc | Kevin Geoffrey Birkett | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 19,755 | 19,755 | - | - | Stock Option |